Abstract:
Nowadays all the fields of sciences such as chemistry, medicines, biology, and pharmacology exploiting the use of a radionuclide as medication or other biologically active molecule. These molecules are very potent and play a very big role in improving human life by treating many diseased conditions. The new techniques have been used in various nuclear drug procedures, the produced radiopharmaceuticals are used for both internal radiation (i.e., noninvasive scintigraphy imaging). This radioligand therapy (RLT), also known as noninvasive scintigraphy imaging. The design, synthesis, radiolabeling, biology, and preclinical assessment of the medicines, as well as their clinical use, are all taken into account during the creation of radiopharmaceuticals. Contributions could be made in the areas of targeted, pretargeted, and non-targeted radiopharmaceuticals, ranging from small molecules through peptides, peptidomimetics, antibodies, and their derivatives, to particles for use in gamma scintigraphy, such as single photon emission tomography (SPECT), positron emission tomography (PET), and endoradiotherapy. Strong interest exists in the fields of diagnostic imaging and (radio) pharmaceutical treatment that are supported by diagnostic imaging. It is also acceptable to take allied subjects including physics, dosimetry, radio pharmacy, and hybrid imaging